Archives
Affordable GRO-seq for Bread Wheat Nascent RNA
2026-09-26
Chen and colleagues describe a bread-wheat GRO-seq workflow that adds ribosomal RNA depletion after nuclear RNA isolation and before nascent-RNA immunoprecipitation. In their application to enhancer transcription in allohexaploid wheat, the protocol increased the reported proportion of valid sequencing data 20-fold, offering a practical way to use sequencing capacity more efficiently in complex genomes.
SP600125 and the Translational Logic of JNK
2026-09-25
A mechanistic and experimental framework for using SP600125 to test JNK’s contribution to infection-linked inflammatory signaling, while distinguishing pathway evidence from translational hypotheses.
Protease Inhibitor Cocktail for DFCP1–ATGL Studies
2026-09-25
Protect DFCP1, ATGL, and other lipid-droplet proteins during extraction without confusing post-lysis preservation with the biology of starvation-driven lipolysis. This practical guide covers lysate preparation, complex analysis, EDTA-sensitive assays, and troubleshooting with a ready-to-use 100X aqueous inhibitor concentrate.
SB 431542 for Reliable TGF-β Assays
2026-09-24
A scenario-driven guide to using SB 431542 (SKU A8249) to investigate ALK5-dependent signaling, proliferation, and assay interpretation. It combines product data with practical controls and clearly distinguishes pathway evidence from experiments that have not tested the compound.
Budesonide Workflows for Lung Permeability Research
2026-09-24
Use Budesonide to connect airway inflammation assays with biomimetic lung-permeability screening—while keeping those readouts distinct. This workflow translates recent IAM-LC and OT-CEC findings into practical compound handling, assay selection, and troubleshooting guidance for respiratory disease research.
TAK-242 (Resatorvid) for Reliable Cell Assays
2026-09-24
Practical guidance for using TAK-242 (Resatorvid), SKU A3850, to investigate LPS-triggered TLR4 signaling without mistaking inflammatory changes for cell loss. Covers assay controls, solvent handling, interpretation, and the context-dependent limits of pathway inhibition.
Sumatriptan as an Anti-Inflammatory Agent
2026-09-23
This systematic review evaluates evidence that sumatriptan, beyond its established migraine and cluster-headache indications, can modulate inflammatory signaling through 5-HT1B/1D receptors, nitric oxide pathways, CGRP release, and cytokine-associated mechanisms. Its findings support pharmacological repositioning as a research hypothesis, while the heterogeneous preclinical evidence requires careful separation of mechanistic plausibility from clinical efficacy.
Phosphatase Inhibitor Cocktail: Phospho Workflow
2026-09-22
Protect labile phosphorylation signals from lysis through immunoblotting, kinase assays, immunoprecipitation, and phosphoproteomics with a dual-component 100X system. Its sequential serine/threonine and tyrosine phosphatase coverage is especially useful when mapping stress-responsive pathways such as ROS–ZAKα–MAPK signaling.
EZ Cap™ Human PTEN mRNA (ψUTP) Workflow
2026-09-22
Build reproducible PTEN-expression assays with Cap 1, pseudouridine-modified mRNA designed for efficient mammalian translation and reduced innate immune activation. This workflow connects formulation, pathway readouts, and trastuzumab-resistance models while separating product capabilities from delivery-system variables.
Z-LEHD-FMK for Time-Resolved Apoptosis Assays
2026-09-21
Z-LEHD-FMK is an irreversible caspase-9 inhibitor for dissecting mitochondria-mediated apoptosis. This guide connects caspase pathway inhibition with annexin-V-based temporal analysis to improve apoptosis assay design in cardiovascular, cancer, and neuroprotection research.
Protease Inhibitor Cocktail for DFCP1–ATGL Assays
2026-09-21
Protect DFCP1–ATGL complexes, lipid-droplet proteins, and tissue-extract targets with a water-soluble 100X formulation designed for rapid extraction workflows. This guide shows how to preserve protein integrity while managing EDTA-sensitive binding, enzyme, purification, and kinase-assay endpoints.
How p38α Conformation Directs Dephosphorylation
2026-09-20
The reference preprint shows that selected kinase inhibitors can both block p38α catalysis and accelerate WIP1-mediated removal of the activation-loop phosphothreonine. Its biochemical assays and X-ray structures establish kinase conformation as a potential lever for improving the specificity and durability of p38 pathway inhibition.
Protease Inhibitor Cocktail for DFCP1–ATGL Assays
2026-09-19
Preserve DFCP1–ATGL complexes, phosphoprotein signals, and labile lipid-droplet regulators during cell or tissue extraction. This workflow shows how an EDTA-containing Protease Inhibitor Cocktail can improve reproducibility while flagging compatibility limits for metal-dependent assays and purification.
ONC201 Rewires Metabolism and Epigenetics in DMG
2026-09-19
The reference study links ONC201 activity in H3K27M-mutant diffuse midline glioma to coordinated metabolic and epigenetic changes rather than a single downstream pathway. Clinical timing, tumor sequencing, cultured-cell experiments, cerebrospinal fluid measurements, and tumor tissue analyses together show that treatment-associated 2-hydroxyglutarate accumulation coincides with restoration of repressive H3K27me3 and suppression of malignant transcriptional programs.
Cap 1 mRNA as a Translation Benchmark
2026-09-18
A translational framework for using EZ Cap™ Firefly Luciferase mRNA to separate RNA quality, delivery performance, and biological response in modern mRNA studies.